STAGE III LUNG CANCER AJCC V8
Clinical trials for STAGE III LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mayo clinic tests higher radiation dose to control tough lung cancers
Disease control CompletedThis study tested whether a higher dose of proton beam radiation works better than a standard dose when combined with chemotherapy for patients with inoperable stage 2 or 3 non-small cell lung cancer. Twenty patients were randomly assigned to receive either 60 Gy or 72 Gy of prot…
Matched conditions: STAGE III LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Scientists test Triple-Threat combo to supercharge immune system against lung cancer
Disease control CompletedThis early-stage trial tested the safety of combining radiation therapy with one or two new immunotherapy drugs for patients with a specific type of advanced lung cancer. The study involved 26 adults whose cancer had spread locally but not to distant organs and who had high level…
Matched conditions: STAGE III LUNG CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New support program aims to ease burden on lung cancer caregivers
Symptom relief CompletedThis study tested a new wellness coaching program designed to support people caring for loved ones with advanced lung cancer. It compared standard support materials to the new coaching sessions to see which better helped caregivers manage stress and burden. The goal was to improv…
Matched conditions: STAGE III LUNG CANCER AJCC V8
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Mar 05, 2026 14:00 UTC
-
Scientists bank cancer samples to crack treatment resistance code
Knowledge-focused CompletedThis study collected blood and tumor tissue samples from 64 patients with advanced cancers to build a research library. The goal was to understand why cancers stop responding to treatments and to find better ways to match future patients with effective therapies. Samples were tak…
Matched conditions: STAGE III LUNG CANCER AJCC V8
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 13, 2026 15:06 UTC